Dr Singal reviews the Child-Pugh scoring system, then Dr Lewandowski discusses the importance of considering liver function as well as disease burden when selecting a treatment strategy.
FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs
D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor
FAK Inhibition Emerges as a Potential Complementary Treatment Pathway
Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent
Durvalumab Plus Chemo Sustains 3-Year OS Benefit in Advanced Biliary Tract Cancer
March Approval Madness: OncLive’s Roundup of FDA Decisions in Oncology
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma